{"id":"W4408980253","doi":"10.1016/s1556-0864(25)00379-x","title":"LBA4: Osimertinib (osi) after definitive chemoradiotherapy (CRT) in patients (pts) with unresectable (UR) stage III EGFR-mutated (EGFRm) non-small cell lung cancer (NSCLC): Updated overall survival (OS) analysis from the LAURA study","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Medicine; Osimertinib; Chemoradiotherapy; Oncology; Internal medicine; Stage (stratigraphy); non-small cell lung cancer (NSCLC); Lung cancer; Overall survival; Cancer; Epidermal growth factor receptor; A549 cell; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001345505,0.0005749426,0.001067326,0.000571685,0.0002084984,0.001077018,0.0007683251,0.0004812649,0.002290645],"category_scores_gemma":[0.001438319,0.0002337237,0.001762,0.000936211,0.0003240346,0.000936355,0.0006153918,0.001135984,0.0004206277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00104123,"about_ca_system_score_gemma":0.0007533127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002649771,"about_ca_topic_score_gemma":0.01059832,"domain_scores_codex":[0.9995049,0.0001886984,0.00004414181,0.00009968507,0.00007852582,0.00008404442],"domain_scores_gemma":[0.9993014,0.0001425133,0.0003300326,0.00005127867,0.00005602691,0.0001188498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1540927,0.0009650261,0.5963534,0.002226022,0.01147708,0.0002541052,0.0001806047,0.005115012,0.004299308,0.0005369638,0.01415646,0.2103433],"study_design_scores_gemma":[0.02008157,0.0153476,0.9269195,0.0005717693,0.01347121,0.0005458884,0.0002226428,0.003161737,0.001559791,0.001031059,0.01699517,0.00009213449],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.974921,0.01266544,0.0003320497,0.0005752173,0.00009116279,0.0001317067,0.007703571,0.00007628516,0.003503687],"genre_scores_gemma":[0.9809068,0.003065687,0.000535362,0.0005468724,0.0001284723,0.0001840695,0.01276303,0.00002387994,0.001845766],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002649771,"threshold_uncertainty_score":0.007662952,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0109457231363197,"score_gpt":0.3781955211780815,"score_spread":0.3672497980417618,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}